Related Experiment Video
Updated: Nov 26, 2025
07:47
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.9K
AMIGO2 Expression as a Potential Prognostic Biomarker for Gastric Cancer
Shunsuke Nakamura1, Mitsuro Kanda2, Dai Shimizu1
1Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan.
Anticancer Research
|December 8, 2020
Summary
High expression of Adhesion molecule with Ig like domain 2 (AMIGO2) in gastric cancer (GC) correlates with poor prognosis. This finding suggests AMIGO2 may serve as a valuable prognostic biomarker for GC patients, improving survival prediction.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gastric cancer (GC) development and progression mechanisms are increasingly understood, yet clinical outcomes remain suboptimal.
- Identifying novel molecular markers is crucial for improving GC patient prognosis and treatment strategies.
Purpose of the Study:
- To identify key molecules involved in gastric cancer progression and metastasis.
- To investigate the potential of identified molecules as prognostic biomarkers for GC.
Main Methods:
- Transcriptome analysis of surgically resected gastric tissues from patients with hepatic metastasis.
- mRNA expression analysis in 14 gastric cancer cell lines and 230 primary GC tissues versus adjacent normal tissues.
Main Results:
- Adhesion molecule with Ig like domain 2 (AMIGO2) was identified as a significant gene of interest.
- High AMIGO2 mRNA levels positively correlated with FOXC2, NODAL, and GEMIN2, and negatively with TFPI2.
- Elevated AMIGO2 expression was significantly associated with shorter disease-free and overall survival in GC patients, indicating a poor prognosis.
Conclusions:
- High AMIGO2 mRNA levels in gastric cancer patients are linked to significantly reduced survival rates.
- AMIGO2 demonstrates potential as a prognostic biomarker for predicting outcomes in gastric cancer.
